Your institution may have access to this item. Find your institution then sign in to continue.
Title
People.
Abstract
The article announces that Christian Groendahl was appointed Chief executive officers (CEO) and David A. Roth was appointed senior vice president at Kymab Ltd. and Infinity Pharmaceuticals Inc. and Richard Mason was appointed CEO at Biotech startup XO1 Ltd., at Cambridge in Massachusetts.